CaV1.2 signaling complexes in the heart

Journal of Molecular and Cellular Cardiology

Volumn 58, Issue 1, 2013, Pages 143-152

  Harvey, Robert D ^a   Hell, Johannes W ^b  

^a UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adrenergic receptor; A kinase anchoring protein; Calcium channel; Cardiac myocyte; E type prostaglandin receptor; Protein kinase A

Indexed keywords

ADENYLATE CYCLASE; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; CALCIUM CHANNEL L TYPE; CAVEOLIN 3; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN 5; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN 7; G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; PHOSPHODIESTERASE I; PHOSPHODIESTERASE III; PHOSPHODIESTERASE IV; PHOSPHOPROTEIN PHOSPHATASE 1; PHOSPHOPROTEIN PHOSPHATASE 2A; PROSTAGLANDIN RECEPTOR; PROTEIN KINASE C; RYANODINE RECEPTOR 2; SPLEEN EXONUCLEASE; UNCLASSIFIED DRUG; VOLTAGE DEPENDENT CALCIUM ION CHANNEL 1.1; VOLTAGE DEPENDENT CALCIUM ION CHANNEL 1.2; VOLTAGE DEPENDENT CALCIUM ION CHANNEL 1.3; VOLTAGE DEPENDENT CALCIUM ION CHANNEL 1.4; BETA ADRENERGIC RECEPTOR; CALCIUM; L TYPE CALCIUM CHANNEL ALPHA(1C); L-TYPE CALCIUM CHANNEL ALPHA(1C); PROSTAGLANDIN E RECEPTOR;

CALCIUM SIGNALING; CALCIUM TRANSPORT; CAVEOLA; CHANNEL GATING; CHEMICAL STRUCTURE; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; EXCITATION CONTRACTION COUPLING; HEART MUSCLE CELL; IMMUNOPRECIPITATION; LIPID RAFT; MEMBRANE DEPOLARIZATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN HYDROLYSIS; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; REVIEW; HEART MUSCLE; HUMAN; METABOLISM; PATHOLOGY; PHYSIOLOGY;

A KINASE ANCHOR PROTEINS; CALCIUM; CALCIUM CHANNELS, L-TYPE; CALCIUM SIGNALING; CYCLIC AMP-DEPENDENT PROTEIN KINASES; HUMANS; MYOCARDIUM; MYOCYTES, CARDIAC; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, PROSTAGLANDIN E;

EID: 84876324198     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2012.12.006     Document Type: Review

References (157)

1. Dai S., Hall D.D., Hell J.W. Supramolecular assemblies and localized regulation of voltage-gated ion channels. Physiol Rev 2009, 89:411-452.
2. 2+ channels exhibit unique regulation and functional roles in cardiomyocytes. J Mol Cell Cardiol 2012, 52:376-387.
3. Beene D.L., Scott J.D. A-kinase anchoring proteins take shape. Curr Opin Cell Biol 2007, 19:192-198.
4. Carafoli E. Calcium signaling: a tale for all seasons. Proc Natl Acad Sci U S A 2002, 99:1115-1122.
5. Clapham D.E. Calcium signaling. Cell 1995, 80:259-268.
6. Bers D.M. Cardiac excitation-contraction coupling. Nature 2002, 415:198-205.
7. 2+ channels. Annu Rev Cell Dev Biol 2000, 16:521-555.
8. Bers D.M., Perez-Reyes E. Ca channels in cardiac myocytes: structure and function in Ca influx and intracellular Ca release. Cardiovasc Res 1999, 42:339-360.
9. Gao T., Cuadra A.E., Ma H., Bunemann M., Gerhardstein B.L., Cheng T., et al. C-terminal fragments of the alpha 1C (CaV1.2) subunit associate with and regulate L-type calcium channels containing C-terminal-truncated alpha 1C subunits. J Biol Chem 2001, 276:21089-21097.
10. Gao T., Puri T.S., Gerhardstein B.L., Chien A.J., Green R.D., Hosey M.M. Identification and subcellular localization of the subunits of L-type calcium channels and adenylyl cyclase in cardiac myocytes. J Biol Chem 1997, 272:19401-19407.
11. Gerhardstein B.L., Gao T., Bunemann M., Puri T.S., Adair A., Ma H., et al. Proteolytic processing of the C terminus of the alpha(1C) subunit of L-type calcium channels and the role of a proline-rich domain in membrane tethering of proteolytic fragments. J Biol Chem 2000, 275:8556-8563.
12. Hulme J.T., Yarov-Yarovoy V., Lin T.W., Scheuer T., Catterall W.A. Autoinhibitory control of the CaV1.2 channel by its proteolytically processed distal C-terminal domain. J Physiol 2006, 576:87-102.
13. Mikala G., Klockner U., Varadi M., Eisfeld J., Schwartz A., Varadi G. cAMP-dependent phosphorylation sites and macroscopic activity of recombinant cardiac L-type calcium channels. Mol Cell Biochem 1998, 185:95-109.
14. 2+ channels. J Biol Chem 1991, 266:21943-21947.
15. De Jongh K.S., Murphy B.J., Colvin A.A., Hell J.W., Takahashi M., Catterall W.A. Specific phosphorylation of a site in the full-length form of the alpha 1 subunit of the cardiac L-type calcium channel by adenosine 3',5'-cyclic monophosphate-dependent protein kinase. Biochemistry 1996, 35:10392-10402.
16. Gomez-Ospina N., Tsuruta F., Barreto-Chang O., Hu L., Dolmetsch R. The C terminus of the L-type voltage-gated calcium channel Ca(V)1.2 encodes a transcription factor. Cell 2006, 127:591-606.
17. Foell J.D., Balijepalli R.C., Delisle B.P., Yunker A.M., Robia S.L., Walker J.W., et al. Molecular heterogeneity of calcium channel beta-subunits in canine and human heart: evidence for differential subcellular localization. Physiol Genomics 2004, 17:183-200.
18. Singer D., Biel M., Lotan I., Flockerzi V., Hofmann F., Dascal N. The roles of the subunits in the function of the calcium channel. Science 1991, 253:1553-1557.
19. Kamp T.J., Perez-Garcia M.T., Marban E. Enhancement of ionic current and charge movement by coexpression of calcium channel beta 1A subunit with alpha 1C subunit in a human embryonic kidney cell line. J Physiol 1996, 492(Pt 1):89-96.
20. 2+ channels. J Biol Chem 1995, 270:30036-30044.
21. Jay S.D., Sharp A.H., Kahl S.D., Vedvick T.S., Harpold M.M., Campbell K.P. Structural characterization of the dihydropyridine-sensitive calcium channel alpha 2-subunit and the associated delta peptides. J Biol Chem 1991, 266:3287-3293.
22. Bangalore R., Mehrke G., Gingrich K., Hofmann F., Kass R.S. Influence of L-type Ca channel alpha 2/delta-subunit on ionic and gating current in transiently transfected HEK 293 cells. Am J Physiol 1996, 270:H1521-H1528.
23. Dolphin A.C. Calcium channel auxiliary alpha(2)delta and beta subunits: trafficking and one step beyond. Nat Rev Neurosci 2012, 13:542-555.
24. Yang L., Katchman A., Morrow J.P., Doshi D., Marx S.O. Cardiac L-type calcium channel (Cav1.2) associates with gamma subunits. FASEB J 2011, 25:928-936.
25. Antzelevitch C. Role of spatial dispersion of repolarization in inherited and acquired sudden cardiac death syndromes. Am J Physiol Heart Circ Physiol 2007, 293:H2024-H2038.
26. Splawski I., Timothy K.W., Sharpe L.M., Decher N., Kumar P., Bloise R., et al. Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell 2004, 119:19-31.
27. Antzelevitch C., Pollevick G.D., Cordeiro J.M., Casis O., Sanguinetti M.C., Aizawa Y., et al. Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death. Circulation 2007, 115:442-449.
28. Reuter H. Calcium channel modulation by neurotransmitters, enzymes and drugs. Nature 1983, 301:569-574.
29. Levitzki A. From epinephrine to cyclic AMP. Science 1988, 241:800-805.
30. Rochais F., bi-Gerges A., Horner K., Lefebvre F., Cooper D.M., Conti M., et al. A specific pattern of phosphodiesterases controls the cAMP signals generated by different Gs-coupled receptors in adult rat ventricular myocytes. Circ Res 2006, 98:1081-1088.
31. 2+ channel regulation in guinea-pig ventricular myocytes. J Physiol 2007, 580:765-776.
32. Agarwal S.R., Macdougall D.A., Tyser R., Pugh S.D., Calaghan S.C., Harvey R.D. Effects of cholesterol depletion on compartmentalized cAMP responses in adult cardiac myocytes. J Mol Cell Cardiol 2011, 50:500-509.
33. Calaghan S., White E. Caveolae modulate excitation-contraction coupling and beta2-adrenergic signalling in adult rat ventricular myocytes. Cardiovasc Res 2006, 69:816-824.
34. Xiao R.P., Zhu W., Zheng M., Chakir K., Bond R., Lakatta E.G., et al. Subtype-specific beta-adrenoceptor signaling pathways in the heart and their potential clinical implications. Trends Pharmacol Sci 2004, 25:358-365.
35. 2+ dynamics, contractility, or phospholamban phosphorylation. J Biol Chem 1994, 269:19151-19156.
36. 2+ current in single rat ventricular cells. Circ Res 1993, 73:286-300.
37. 2-adrenergic stimulation. Circulation 1995, 92:1612-1618.
38. Kuschel M., Zhou Y.Y., Spurgeon H.A., Bartel S., Karczewski P., Zhang S.J., et al. Beta2-adrenergic cAMP signaling is uncoupled from phosphorylation of cytoplasmic proteins in canine heart. Circulation 1999, 99:2458-2465.
39. Calaghan S., Kozera L., White E. Compartmentalisation of cAMP-dependent signalling by caveolae in the adult cardiac myocyte. J Mol Cell Cardiol 2008, 45:88-92.
40. Chen-Izu Y., Xiao R.P., Izu L.T., Cheng H., Kuschel M., Spurgeon H., et al. G(i)-dependent localization of beta(2)-adrenergic receptor signaling to L-type Ca(2+) channels. Biophys J 2000, 79:2547-2556.
41. 2+ channel Cav1.2. Science 2001, 293:98-101.
42. Macdougall D.A., Agarwal S.R., Stopford E.A., Chu H., Collins J.A., Longster A.L., et al. Caveolae compartmentalise beta2-adrenoceptor signals by curtailing cAMP production and maintaining phosphatase activity in the sarcoplasmic reticulum of the adult ventricular myocyte. J Mol Cell Cardiol 2012, 52:388-400.
43. Nikolaev V.O., Moshkov A., Lyon A.R., Miragoli M., Novak P., Paur H., et al. Beta2-adrenergic receptor redistribution in heart failure changes cAMP compartmentation. Science 2010, 327:1653-1657.
44. Balijepalli R.C., Foell J.D., Hall D.D., Hell J.W., Kamp T.J. Localization of cardiac L-type Ca(2+) channels to a caveolar macromolecular signaling complex is required for beta(2)-adrenergic regulation. Proc Natl Acad Sci U S A 2006, 103:7500-7505.
45. Qian H., Matt L., Zhang M., Nguyen M., Patriarchi T., Koval O.M., et al. β2-Adrenergic receptor supports prolonged theta tetanus-induced LTP. J Neurophysiol 2012, 107:2703-2712.
46. Nichols C.B., Rossow C.F., Navedo M.F., Westenbroek R.E., Catterall W.A., Santana L.F., et al. Sympathetic stimulation of adult cardiomyocytes requires association of AKAP5 with a subpopulation of L-type calcium channels. Circ Res 2010, 107:747-756.
47. Hayes J.S., Brunton L.L., Mayer S.E. Selective activation of particulate cAMP-dependent protein kinase by isoproterenol and prostaglandin E1. J Biol Chem 1980, 255:5113-5119.
48. Saucerman J.J., Zhang J., Martin J.C., Peng L.X., Stenbit A.E., Tsien R.Y., et al. Systems analysis of PKA-mediated phosphorylation gradients in live cardiac myocytes. Proc Natl Acad Sci U S A 2006, 103:12923-12928.
49. Di Benedetto G., Zoccarato A., Lissandron V., Terrin A., Li X., Houslay M.D., et al. Protein kinase A type I and type II define distinct intracellular signaling compartments. Circ Res 2008, 103:836-844.
50. Buxton I.L., Brunton L.L. Compartments of cyclic AMP and protein kinase in mammalian cardiomyocytes. J Biol Chem 1983, 258:10233-10239.
51. Warrier S., Belevych A.E., Ruse M., Eckert R.L., Zaccolo M., Pozzan T., et al. Beta-adrenergic and muscarinic receptor induced changes in cAMP activity in adult cardiac myocytes detected using a FRET based biosensor. Am J Physiol 2005, 289:C455-C461.
52. Liu S., Li Y., Kim S., Fu Q., Parikh D., Sridhar B., et al. Phosphodiesterases coordinate cAMP propagation induced by two stimulatory G protein-coupled receptors in hearts. Proc Natl Acad Sci U S A 2012, 109:6578-6583.
53. Tolkovsky A.M., Levitzki A. Theories and predictions of models describing sequential interactions between the receptor, the GTP regulatory unit, and the catalytic unit of hormone dependent adenylate cyclases. J Cyclic Nucleotide Res 1981, 7:139-150.
54. Schlegel W., Kempner E.S., Rodbell M. Activation of adenylate cyclase in hepatic membranes involves interactions of the catalytic unit with multimeric complexes of regulatory proteins. J Biol Chem 1979, 254:5168-5176.
55. Kuschel M., Zhou Y.Y., Cheng H., Zhang S.J., Chen Y., Lakatta E.G., et al. G(i) protein-mediated functional compartmentalization of cardiac beta(2)-adrenergic signaling. J Biol Chem 1999, 274:22048-22052.
56. Zhou Y.Y., Cheng H., Bogdanov K.Y., Hohl C., Altschuld R., Lakatta E.G., et al. Localized cAMP-dependent signaling mediates beta 2-adrenergic modulation of cardiac excitation-contraction coupling. Am J Physiol 1997, 273:H1611-H1618.
57. Belevych A.E., Juranek I., Harvey R.D. Protein kinase C regulates functional coupling of beta1-adrenergic receptors to Gi/o-mediated responses in cardiac myocytes. FASEB J 2004, 18:367-369.
58. Bauman A.L., Soughayer J., Nguyen B.T., Willoughby D., Carnegie G.K., Wong W., et al. Dynamic regulation of cAMP synthesis through anchored PKA-adenylyl cyclase V/VI complexes. Mol Cell 2006, 23:925-931.
59. Efendiev R., Samelson B.K., Nguyen B.T., Phatarpekar P.V., Baameur F., Scott J.D., et al. AKAP79 interacts with multiple adenylyl cyclase (AC) isoforms and scaffolds AC5 and -6 to alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate (AMPA) receptors. J Biol Chem 2010, 285:14450-14458.
60. Ishikawa Y., Homcy C.J. The adenylyl cyclases as integrators of transmembrane signal transduction. Circ Res 1997, 80:297-304.
61. Piggott L.A., Bauman A.L., Scott J.D., Dessauer C.W. The A-kinase anchoring protein Yotiao binds and regulates adenylyl cyclase in brain. Proc Natl Acad Sci U S A 2008, 105:13835-13840.
62. Kapiloff M.S., Piggott L.A., Sadana R., Li J., Heredia L.A., Henson E., et al. An adenylyl cyclase-mAKAPbeta signaling complex regulates cAMP levels in cardiac myocytes. J Biol Chem 2009, 284:23540-23546.
63. Fischmeister R., Castro L.R., bi-Gerges A., Rochais F., Jurevicius J., Leroy J., et al. Compartmentation of cyclic nucleotide signaling in the heart: the role of cyclic nucleotide phosphodiesterases. Circ Res 2006, 99:816-828.
64. Mika D., Leroy J., Vandecasteele G., Fischmeister R. PDEs create local domains of cAMP signaling. J Mol Cell Cardiol 2012, 52:323-329.
65. 2+ channels by β-adrenergic agonists. Proc Natl Acad Sci USA 1996, 93:295-299.
66. ++ current in cardiac myocytes. J Pharmacol Exp Ther 1997, 283:452-461.
67. Marcantoni A., Levi R.C., Gallo M.P., Hirsch E., Alloatti G. Phosphoinositide 3-kinasegamma (PI3Kgamma) controls L-type calcium current (ICa, L) through its positive modulation of type-3 phosphodiesterase (PDE3). J Cell Physiol 2006, 206:329-336.
68. Kerfant B.G., Zhao D., Lorenzen-Schmidt I., Wilson L.S., Cai S., Chen S.R., et al. PI3Kgamma is required for PDE4, not PDE3, activity in subcellular microdomains containing the sarcoplasmic reticular calcium ATPase in cardiomyocytes. Circ Res 2007, 101:400-408.
69. Iancu R.V., Jones S.W., Harvey R.D. Compartmentation of cAMP signaling in cardiac myocytes: a computational study. Biophys J 2007, 92:3317-3331.
70. Baillie G.S., Sood A., McPhee I., Gall I., Perry S.J., Lefkowitz R.J., et al. beta-Arrestin-mediated PDE4 cAMP phosphodiesterase recruitment regulates beta-adrenoceptor switching from Gs to Gi. Proc Natl Acad Sci U S A 2003, 100:940-945.
71. Perry S.J., Baillie G.S., Kohout T.A., McPhee I., Magiera M.M., Ang K.L., et al. Targeting of cyclic AMP degradation to beta 2-adrenergic receptors by beta-arrestins. Science 2002, 298:834-836.
72. De A.V., Liu R., Soto D., Xiang Y. Differential association of phosphodiesterase 4D isoforms with beta2-adrenoceptor in cardiac myocytes. J Biol Chem 2009, 284:33824-33832.
73. Dodge-Kafka K.L., Soughayer J., Pare G.C., Carlisle Michel J.J., Langeberg L.K., Kapiloff M.S., et al. The protein kinase A anchoring protein mAKAP coordinates two integrated cAMP effector pathways. Nature 2005, 437:574-578.
74. Dodge K.L., Khouangsathiene S., Kapiloff M.S., Mouton R., Hill E.V., Houslay M.D., et al. mAKAP assembles a protein kinase A/PDE4 phosphodiesterase cAMP signaling module. EMBO J 2001, 20:1921-1930.
75. Tasken K.A., Collas P., Kemmner W.A., Witczak O., Conti M., Tasken K. Phosphodiesterase 4D and protein kinase a type II constitute a signaling unit in the centrosomal area. J Biol Chem 2001, 276:21999-22002.
76. Willoughby D., Wong W., Schaack J., Scott J.D., Cooper D.M. An anchored PKA and PDE4 complex regulates subplasmalemmal cAMP dynamics. EMBO J 2006, 25:2051-2061.
77. Conti M., Richter W., Mehats C., Livera G., Park J.Y., Jin C. Cyclic AMP-specific PDE4 phosphodiesterases as critical components of cyclic AMP signaling. J Biol Chem 2003, 278:5493-5496.
78. Leroy J., Richter W., Mika D., Castro L.R., Abi-Gerges A., Xie M., et al. Phosphodiesterase 4B in the cardiac L-type Ca(2)(+) channel complex regulates Ca(2)(+) current and protects against ventricular arrhythmias in mice. J Clin Invest 2011, 121:2651-2661.
79. Lehnart S.E., Wehrens X.H., Reiken S., Warrier S., Belevych A.E., Harvey R.D., et al. Phosphodiesterase 4D deficiency in the ryanodine-receptor complex promotes heart failure and arrhythmias. Cell 2005, 123:25-35.
80. +2 current. Nature 1982, 298:576-578.
81. Yoshida A., Takahashi M., Nishimura S., Takeshima H., Kokubun S. Cyclic AMP-dependent phosphorylation and regulation of the cardiac dihydropyridine-sensitive Ca channel. FEBS Lett 1992, 309:343-349.
82. Fu Y., Westenbroek R.E., Yu F.H., Clark J.P., Marshall M.R., Scheuer T., et al. Deletion of the distal C terminus of CaV1.2 channels leads to loss of beta-adrenergic regulation and heart failure in vivo. J Biol Chem 2011, 286:12617-12626.
83. Mitterdorfer J., Froschmayr M., Grabner M., Moebius F.F., Glossmann H., Striessnig J. Identification of PK-A phosphorylation sites in the carboxyl terminus of L-type calcium channel alpha 1 subunits. Biochemistry 1996, 35:9400-9406.
84. Hulme J.T., Westenbroek R.E., Scheuer T., Catterall W.A. Phosphorylation of serine 1928 in the distal C-terminal domain of cardiac CaV1.2 channels during beta1-adrenergic regulation. Proc Natl Acad Sci U S A 2006, 103:16574-16579.
85. 1 subunit. J Biol Chem 1994, 269:1635-1640.
86. Hess P., Lansman J.B., Tsien R.W. Different modes of Ca channel gating behaviour favoured by dihydropyridine Ca agonists and antagonists. Nature 1984, 311:538-544.
87. Yue D.T., Herzig S., Marban E. β-Adrenergic stimulation of calcium channels occurs by potentiation of high-activity gating modes. Proc Natl Acad Sci USA 1990, 87:753-757.
88. Herzig S., Neumann J. Effects of serine/threonine protein phosphatases on ion channels in excitable membranes. Physiol Rev 2000, 80:173-210.
89. Zong X., Schreieck J., Mehrke G., Welling A., Schuster A., Bosse E., et al. On the regulation of the expressed L-type calcium channel by cAMP-dependent phosphorylation. Pflugers Arch 1995, 430:340-347.
90. 2+ channels in cardiac myocytes requires the distal carboxyl terminus of alpha1C but not serine 1928. Circ Res 2006, 98:e11-e18.
91. Lemke T., Welling A., Christel C.J., Blaich A., Bernhard D., Lenhardt P., et al. Unchanged beta-adrenergic stimulation of cardiac L-type calcium channels in Ca v 1.2 phosphorylation site S1928A mutant mice. J Biol Chem 2008, 283:34738-34744.
92. Fuller M.D., Emrick M.A., Sadilek M., Scheuer T., Catterall W.A. Molecular mechanism of calcium channel regulation in the fight-or-flight response. Sci Signal 2010, 3:ra70.
93. 2+ channels requires membrane targeting of PKA and phosphorylation of channel subunits. Neuron 1997, 19:185-196.
94. 2+ channel activity and nuclear signaling. Neuron 2007, 55:261-275.
95. 2+ signaling amplification by oligomerization of L-type Cav1.2 channels. Proc Natl Acad Sci U S A 2012, 109:1749-1754.
96. Bunemann M., Gerhardstein B.L., Gao T., Hosey M.M. Functional regulation of L-type calcium channels via protein kinase A-mediated phosphorylation of the beta(2) subunit. J Biol Chem 1999, 274:33851-33854.
97. Haase H., Karczewski P., Beckert R., Krause E.G. Phosphorylation of the L-type calcium channel beta subunit is involved in beta-adrenergic signal transduction in canine myocardium. FEBS Lett 1993, 335:217-222.
98. Gerhardstein B.L., Puri T.S., Chien A.J., Hosey M.M. Identification of the sites phosphorylated by cyclic AMP-dependent protein kinase on the beta 2 subunit of L-type voltage-dependent calcium channels. Biochemistry 1999, 38:10361-10370.
99. Dolphin A.C. Beta subunits of voltage-gated calcium channels. J Bioenerg Biomembr 2003, 35:599-620.
100. Miriyala J., Nguyen T., Yue D.T., Colecraft H.M. Role of CaVbeta subunits, and lack of functional reserve, in protein kinase A modulation of cardiac CaV1.2 channels. Circ Res 2008, 102:e54-e64.
101. Brandmayr J., Poomvanicha M., Domes K., Ding J., Blaich A., Wegener J.W., et al. Deletion of the C-terminal phosphorylation sites in the cardiac beta-subunit does not affect the basic beta-adrenergic response of the heart and the Cav1.2 channel. J Biol Chem 2012, 287:22584-22592.
102. Haase H., Alvarez J., Petzhold D., Doller A., Behlke J., Erdmann J., et al. Ahnak is critical for cardiac Ca(V)1.2 calcium channel function and its beta-adrenergic regulation. FASEB J 2005, 19:1969-1977.
103. Kamp T.J., Hell J.W. Regulation of cardiac L-type calcium channels by protein kinase A and protein kinase C. Circ Res 2000, 87:1095-1102.
104. McHugh D., Sharp E.M., Scheuer T., Catterall W.A. Inhibition of cardiac L-type calcium channels by protein kinase C phosphorylation of two sites in the N-terminal domain. Proc Natl Acad Sci U S A 2000, 97:12334-12338.
105. Yang L., Liu G., Zakharov S.I., Morrow J.P., Rybin V.O., Steinberg S.F., et al. Ser 1928 is a common site for Cav1.2 phosphorylation by protein kinase C isoforms. J Biol Chem 2005, 280:207-214.
106. Davare M.A., Dong F., Rubin C.S., Hell J.W. The A-kinase anchor protein MAP2B and cAMP-dependent protein kinase are associated with class C L-type calcium channels in neurons. J Biol Chem 1999, 274:30280-30287.
107. 2+ channels. Circ Res 1997, 80:720-729.
108. Klauck T.M., Faux M.C., Labudda K., Langeberg L.K., Jaken S., Scott J.D. Coordination of three signaling enzymes by AKAP79, a mammalian scaffold protein. Science 1996, 271:1589-1592.
109. Ono K., Fozzard H.A. Phosphorylation restores activity of L-type calcium channels after rundown in inside-out patches from rabbit cardiac cells. J Physiol (Lond) 1992, 454:673-688.
110. Wang Y., Townsend C., Rosenberg R.L. Regulation of cardiac L-type Ca channels in planar lipid bilayers by G proteins and protein phosphorylation. Am J Physiol 1993, 264:C1473-C1479.
111. Hescheler J., Kameyama M., Trautwein W., Mieskes G., Soling H.D. Regulation of the cardiac calcium channel by protein phosphatases. Eur J Biochem 1987, 165:261-266.
112. Kameyama M., Hescheler W., Mieskes G., Trautwein W. The protein-specific photophatase 1 antagonizes the beta-adrendergic increase of the cardiac Ca current. Pflugers Arch 1986, 407:461-463.
113. Hartzell H.C., Hirayama Y., Petit-Jacques J. Effects of protein phosphatase and kinase inhibitors on the cardiac L-type Ca current suggest two sites are phosphorylated by protein kinase A and another protein kinase. J Gen Physiol 1995, 106:393-414.
114. Frace A.M., Hartzell H.C. Opposite effects of phosphatase inhibitors on L-type calcium and delayed rectifier currents in frog cardiac myocytes. J Physiol (Lond) 1993, 472:305-326.
115. 2+ channel affecting different kinetic functions. J Physiol (Lond) 1993, 470:73-84.
116. 2+ channels. J Physiol (Lond) 1995, 484:583-592.
117. Davare M.A., Horne M.C., Hell J.W. Protein phosphatase 2A is associated with class C L-type calcium channels (Cav1.2) and antagonizes channel phosphorylation by cAMP-dependent protein kinase. J Biol Chem 2000, 275:39710-39717.
118. Xu H., Ginsburg K.S., Hall D.D., Zimmermann M., Stein I.S., Zhang M., et al. Targeting of protein phosphatases PP2A and PP2B to the C-terminus of the L-type calcium channel Ca v1.2. Biochemistry 2010, 49:10298-10307.
119. Hall D.D., Feekes J.A., Arachchige Don A.S., Shi M., Hamid J., Chen L., et al. Binding of protein phosphatase 2A to the L-type calcium channel Cav1.2 next to Ser1928, its main PKA site, is critical for Ser1928 dephosphorylation. Biochemistry 2006, 45:3448-3459.
120. 2+ channels. Pflugers Arch 1995, 429:531-538.
121. 2+ channels in GH3 cells: direct evidence against dephosphorylation by calcineurin. J Membr Biol 1997, 156:53-61.
122. Wang Z., Wilson G.F., Griffith L.C. Calcium/calmodulin-dependent protein kinase II phosphorylates and regulates the Drosophila eag potassium channel. J Biol Chem 2002, 277:24022-24029.
123. 2+ channel. Circ Res 2009, 105:51-60.
124. Doskeland S.O., Maronde E., Gjertsen B.T. The genetic subtypes of cAMP-dependent protein kinase-functionally different or redundant?. Biochim Biophys Acta 1993, 1178:249-258.
125. Dodge-Kafka K.L., Langeberg L., Scott J.D. Compartmentation of cyclic nucleotide signaling in the heart: the role of A-kinase anchoring proteins. Circ Res 2006, 98:993-1001.
126. Mauban J.R., O'Donnell M., Warrier S., Manni S., Bond M. AKAP-scaffolding proteins and regulation of cardiac physiology. Physiology (Bethesda) 2009, 24:78-87.
127. Michel J.J., Scott J.D. AKAP mediated signal transduction. Annu Rev Pharmacol Toxicol 2002, 42:235-257.
128. Rubin C.S. A kinase anchor proteins and the intracellular targeting of signals carried by cyclic AMP. Biochim Biophys Acta 1994, 1224:467-479.
129. Wong W., Scott J.D. AKAP signalling complexes: focal points in space and time. Nat Rev Mol Cell Biol 2004, 5:959-970.
130. Dell'Acqua M.L., Faux M.C., Thorburn J., Thorburn A., Scott J.D. Membrane-targeting sequences on AKAP79 bind phosphatidylinositol-4, 5-bisphosphate. EMBO J 1998, 17:2246-2260.
131. Fraser I.D., Tavalin S.J., Lester L.B., Langeberg L.K., Westphal A.M., Dean R.A., et al. A novel lipid-anchored A-kinase anchoring protein facilitates cAMP-responsive membrane events. EMBO J 1998, 17:2261-2272.
132. Welch E.J., Jones B.W., Scott J.D. Networking with AKAPs: context-dependent regulation of anchored enzymes. Mol Interv 2010, 10:86-97.
133. Rosenmund C., Carr D.W., Bergeson S.E., Nilaver G., Scott J.D., Westbrook G.L. Anchoring of protein kinase A is required for modulation of AMPA/kainate receptors on hippocampal neurons. Nature 1994, 368:853-856.
134. Hall D.D., Davare M.A., Shi M., Allen M.L., Weisenhaus M., McKnight G.S., et al. Critical role of cAMP-dependent protein kinase anchoring to the L-type calcium channel Cav1.2 via A-kinase anchor protein 150 in neurons. Biochemistry 2007, 46:1635-1646.
135. Hulme J.T., Lin T.W., Westenbroek R.E., Scheuer T., Catterall W.A. Beta-adrenergic regulation requires direct anchoring of PKA to cardiac CaV1.2 channels via a leucine zipper interaction with A kinase-anchoring protein 15. Proc Natl Acad Sci U S A 2003, 100:13093-13098.
136. Jones B.W., Brunet S., Gilbert M.L., Nichols C.B., Su T., Westenbroek R.E., et al. Cardiomyocytes from AKAP7 knockout mice respond normally to adrenergic stimulation. Proc Natl Acad Sci U S A 2012, 109:17099-17104.
137. Marx S.O., Reiken S., Hisamatsu Y., Gaburjakova M., Gaburjakova J., Yang Y.M., et al. Phosphorylation-dependent regulation of ryanodine receptors: a novel role for leucine/isoleucine zippers. J Cell Biol 2001, 153:699-708.
138. Marx S.O., Kurokawa J., Reiken S., Motoike H., D'Armiento J., Marks A.R., et al. Requirement of a macromolecular signaling complex for beta adrenergic receptor modulation of the KCNQ1-KCNE1 potassium channel. Science 2002, 295:496-499.
139. Baisamy L., Jurisch N., Diviani D. Leucine zipper-mediated homo-oligomerization regulates the Rho-GEF activity of AKAP-Lbc. J Biol Chem 2005, 280:15405-15412.
140. Insel P.A., Head B.P., Ostrom R.S., Patel H.H., Swaney J.S., Tang C.M., et al. Caveolae and lipid rafts: G protein-coupled receptor signaling microdomains in cardiac myocytes. Ann N Y Acad Sci 2005, 1047:166-172.
141. Balijepalli R.C., Kamp T.J. Caveolae, ion channels and cardiac arrhythmias. Prog Biophys Mol Biol 2008, 98:149-160.
142. Harvey R.D., Calaghan S.C. Caveolae create local signalling domains through their distinct protein content, lipid profile and morphology. J Mol Cell Cardiol 2012, 52:366-375.
143. Ostrom R.S., Insel P.A. Methods for the study of signaling molecules in membrane lipid rafts and caveolae. Methods Mol Biol 2006, 332:181-191.
144. Van Deurs B., Roepstorff K., Hommelgaard A.M., Sandvig K. Caveolae: anchored, multifunctional platforms in the lipid ocean. Trends Cell Biol 2003, 13:92-100.
145. Razani B., Woodman S.E., Lisanti M.P. Caveolae: from cell biology to animal physiology. Pharmacol Rev 2002, 54:431-467.
146. Head B.P., Patel H.H., Roth D.M., Lai N.C., Niesman I.R., Farquhar M.G., et al. G-protein-coupled receptor signaling components localize in both sarcolemmal and intracellular caveolin-3-associated microdomains in adult cardiac myocytes. J Biol Chem 2005, 280:31036-31044.
147. Insel P.A., Head B.P., Patel H.H., Roth D.M., Bundey R.A., Swaney J.S. Compartmentation of G-protein-coupled receptors and their signalling components in lipid rafts and caveolae. Biochem Soc Trans 2005, 33:1131-1134.
148. Rybin V.O., Xu X., Lisanti M.P., Steinberg S.F. Differential targeting of beta -adrenergic receptor subtypes and adenylyl cyclase to cardiomyocyte caveolae. A mechanism to functionally regulate the cAMP signaling pathway. J Biol Chem 2000, 275:41447-41457.
149. Patel H.H., Murray F., Insel P.A. Caveolae as organizers of pharmacologically relevant signal transduction molecules. Annu Rev Pharmacol Toxicol 2008, 48:359-391.
150. Levin K.R., Page E. Quantitative studies on plasmalemmal folds and caveolae of rabbit ventricular myocardial cells. Circ Res 1980, 46:244-255.
151. Ostrom R.S., Insel P.A. The evolving role of lipid rafts and caveolae in G protein-coupled receptor signaling: implications for molecular pharmacology. Br J Pharmacol 2004, 143:235-245.
152. Qanbar R., Bouvier M. Role of palmitoylation/depalmitoylation reactions in G-protein-coupled receptor function. Pharmacol Ther 2003, 97:1-33.
153. Delint-Ramirez I., Willoughby D., Hammond G.V., Ayling L.J., Cooper D.M. Palmitoylation targets AKAP79 protein to lipid rafts and promotes its regulation of calcium-sensitive adenylyl cyclase type 8. J Biol Chem 2011, 286:32962-32975.
154. Dunphy J.T., Linder M.E. Signalling functions of protein palmitoylation. Biochim Biophys Acta 1998, 1436:245-261.
155. Galbiati F., Volonte D., Minetti C., Chu J.B., Lisanti M.P. Phenotypic behavior of caveolin-3 mutations that cause autosomal dominant limb girdle muscular dystrophy (LGMD-1C). Retention of LGMD-1C caveolin-3 mutants within the golgi complex. J Biol Chem 1999, 274:25632-25641.
156. Christian A.E., Haynes M.P., Phillips M.C., Rothblat G.H. Use of cyclodextrins for manipulating cellular cholesterol content. J Lipid Res 1997, 38:2264-2272.
157. Toya Y., Schwencke C., Couet J., Lisanti M.P., Ishikawa Y. Inhibition of adenylyl cyclase by caveolin peptides. Endocrinology 1998, 139:2025-2031.